Systematic Review of Antifungal-Induced Acute Liver Failure

Link to article at PubMed

Cureus. 2021 Oct 21;13(10):e18940. doi: 10.7759/cureus.18940. eCollection 2021 Oct.


Antifungals are effective antimicrobial agents broadly used in medical practice. Severe acute liver failure from oral or IV administration of antifungals is a rare but long-standing clinical challenge. We aimed to approximate the risk of clinical acute liver injury among users of oral antifungals in the general population. This review was completed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Six articles were included, comprising case reports and cohort studies, after eliminating duplicate publications. No randomized control studies were found. In all studies, the duration of antifungal use was associated with significantly increased liver enzyme levels. Although it is not very common for patients on antifungals to develop acute liver failure, the prognosis is often good with swift discontinuation of the drug and proper treatment. Liver function evaluation before treatment and periodic monitoring every three to six weeks after commencement of treatment is suggested.

PMID:34703680 | PMC:PMC8529939 | DOI:10.7759/cureus.18940

Leave a Reply

Your email address will not be published.